
South & Central America Genetic Testing Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
Description
The genetic testing services market in South and Central America is poised for significant growth, with projections indicating that it will reach approximately US$ 515.91 million by 2031, up from US$ 186.42 million in 2023. This growth trajectory reflects a compound annual growth rate (CAGR) of 13.6% from 2023 to 2031.
Executive Summary and Market Analysis
The expansion of the genetic testing services market in South America is primarily driven by improvements in healthcare infrastructure, heightened awareness of genetic disorders, and an increasing demand for personalized medicine. Key countries such as Brazil, Argentina, and Chile are witnessing a surge in genetic testing applications, particularly in areas like cancer detection, prenatal screening, and the diagnosis of rare genetic diseases. The market is further supported by a growing emphasis on enhancing healthcare services and broadening access to advanced diagnostic tools. Additionally, government initiatives that promote genomic research and increased healthcare investments are expected to further accelerate the adoption of genetic testing across the region, contributing to its growth in the upcoming years.
Market Segmentation Analysis
The genetic testing services market can be segmented based on type, disease, and service provider.
By Type: The market is divided into several categories, including predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, predictive testing emerged as the leading segment in terms of market share.
By Disease: The market is also categorized by disease, including cancer, cardiovascular diseases, metabolic disorders, and other conditions. Cancer testing held the largest market share in 2023, reflecting the growing focus on oncology.
By Service Provider: The market is segmented into hospital-based laboratories, diagnostic laboratories, and other service providers. Hospital-based laboratories dominated the market in 2023, indicating a preference for testing conducted in clinical settings.
Market Outlook
Emerging economies such as Brazil, Mexico, and others present substantial growth opportunities for market participants. This growth is largely attributed to increased public healthcare spending, enhancements in healthcare infrastructure, and a large patient population in need of genetic testing. The rising awareness of genetic disorders and the importance of early diagnosis are also contributing factors to the growing demand for genetic testing in these developing regions.
The accessibility and practicality of genetic testing procedures have positively influenced research and development activities in these areas. Major players in the market are focusing on strategic initiatives such as partnerships, collaborations, and expansions to enhance product availability and distribution networks. For instance, in 2024, MGI Tech entered into an agreement with Sabin Group to advance personalized medicine in Brazil through oncological and germline genomics. Similarly, PlexBio Co., Ltd. announced a strategic partnership with Biomedica Equipamentos e Suprimentos Hospitalares Ltda. to introduce its cancer gene mutation testing products in Brazil, significantly improving access to genetic testing.
In 2022, Nordic Group partnered with a Mexican laboratory to manage its DNAlife genetic testing platform, aiming to enhance personalized healthcare across Latin America. Furthermore, GENOMIKA, a leading genetic testing laboratory in Brazil, collaborated with Veritas to integrate Whole Genome Sequencing into its offerings, emphasizing preventive medicine and clinical genetics.
The increasing consumer awareness regarding direct-to-consumer (DTC) genetic tests in developing economies also presents growth opportunities for the DTC sector.
Country Insights
The South and Central America genetic testing services market is primarily composed of Brazil, Argentina, and other countries in the region, with Brazil holding the largest market share in 2023. The rise in genetic diseases and chronic illnesses is a significant factor driving the growth of the genetic testing market in Brazil. According to a study published in 2021, approximately 53,746 live births in Brazil were affected by rare genetic diseases in 2019-2020, alongside 498 live births with hereditary cancer syndromes. Additionally, the Brazilian Rare Genomes Project reported that around 13.2 million individuals in Brazil are affected by rare diseases.
The increasing demand for personalized medicine and genetic testing for the detection and treatment of these conditions is propelling market growth. The introduction of advanced technologies in disease diagnosis, along with industry players focusing on developing new molecular diagnostic techniques for faster and more accurate results, is expected to further enhance market dynamics.
Company Profiles
Key players in the South and Central America genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America genetic testing services market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America genetic testing services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Executive Summary and Market Analysis
The expansion of the genetic testing services market in South America is primarily driven by improvements in healthcare infrastructure, heightened awareness of genetic disorders, and an increasing demand for personalized medicine. Key countries such as Brazil, Argentina, and Chile are witnessing a surge in genetic testing applications, particularly in areas like cancer detection, prenatal screening, and the diagnosis of rare genetic diseases. The market is further supported by a growing emphasis on enhancing healthcare services and broadening access to advanced diagnostic tools. Additionally, government initiatives that promote genomic research and increased healthcare investments are expected to further accelerate the adoption of genetic testing across the region, contributing to its growth in the upcoming years.
Market Segmentation Analysis
The genetic testing services market can be segmented based on type, disease, and service provider.
By Type: The market is divided into several categories, including predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, predictive testing emerged as the leading segment in terms of market share.
By Disease: The market is also categorized by disease, including cancer, cardiovascular diseases, metabolic disorders, and other conditions. Cancer testing held the largest market share in 2023, reflecting the growing focus on oncology.
By Service Provider: The market is segmented into hospital-based laboratories, diagnostic laboratories, and other service providers. Hospital-based laboratories dominated the market in 2023, indicating a preference for testing conducted in clinical settings.
Market Outlook
Emerging economies such as Brazil, Mexico, and others present substantial growth opportunities for market participants. This growth is largely attributed to increased public healthcare spending, enhancements in healthcare infrastructure, and a large patient population in need of genetic testing. The rising awareness of genetic disorders and the importance of early diagnosis are also contributing factors to the growing demand for genetic testing in these developing regions.
The accessibility and practicality of genetic testing procedures have positively influenced research and development activities in these areas. Major players in the market are focusing on strategic initiatives such as partnerships, collaborations, and expansions to enhance product availability and distribution networks. For instance, in 2024, MGI Tech entered into an agreement with Sabin Group to advance personalized medicine in Brazil through oncological and germline genomics. Similarly, PlexBio Co., Ltd. announced a strategic partnership with Biomedica Equipamentos e Suprimentos Hospitalares Ltda. to introduce its cancer gene mutation testing products in Brazil, significantly improving access to genetic testing.
In 2022, Nordic Group partnered with a Mexican laboratory to manage its DNAlife genetic testing platform, aiming to enhance personalized healthcare across Latin America. Furthermore, GENOMIKA, a leading genetic testing laboratory in Brazil, collaborated with Veritas to integrate Whole Genome Sequencing into its offerings, emphasizing preventive medicine and clinical genetics.
The increasing consumer awareness regarding direct-to-consumer (DTC) genetic tests in developing economies also presents growth opportunities for the DTC sector.
Country Insights
The South and Central America genetic testing services market is primarily composed of Brazil, Argentina, and other countries in the region, with Brazil holding the largest market share in 2023. The rise in genetic diseases and chronic illnesses is a significant factor driving the growth of the genetic testing market in Brazil. According to a study published in 2021, approximately 53,746 live births in Brazil were affected by rare genetic diseases in 2019-2020, alongside 498 live births with hereditary cancer syndromes. Additionally, the Brazilian Rare Genomes Project reported that around 13.2 million individuals in Brazil are affected by rare diseases.
The increasing demand for personalized medicine and genetic testing for the detection and treatment of these conditions is propelling market growth. The introduction of advanced technologies in disease diagnosis, along with industry players focusing on developing new molecular diagnostic techniques for faster and more accurate results, is expected to further enhance market dynamics.
Company Profiles
Key players in the South and Central America genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America genetic testing services market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America genetic testing services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
186 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:
- 4. South and Central America Genetic Testing Services Market – Key Market Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Prevalence of Genetic Diseases
- 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
- 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
- 4.2 Market Restraints
- 4.2.1 Social and Ethical Implications of Genetic Testing
- 4.2.2 Affordability of Genetic Services
- 4.3 Market Opportunities
- 4.3.1 Untapped Emerging Markets in Developing Countries
- 4.4 Future Trends
- 4.4.1 Artificial Intelligence-Powered Genetic Testing
- 4.5 Impact Analysis:
- 5. Genetic Testing Services Market – South and Central America Analysis
- 5.1 South and Central America Genetic Testing Services Market Revenue (US$ Million), 2021–2031
- 5.2 South and Central America Genetic Testing Services Market Forecast Analysis
- 6. South and Central America Genetic Testing Services Market Analysis – by Service Type
- 6.1 Predictive Testing
- 6.1.1 Overview
- 6.1.2 Predictive Testing: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 6.2 Carrier Testing
- 6.2.1 Overview
- 6.2.2 Carrier Testing: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 6.3 Prenatal Testing
- 6.3.1 Overview
- 6.3.2 Prenatal Testing: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 6.4 New-born Screening
- 6.4.1 Overview
- 6.4.2 New-born Screening: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 6.5 Diagnostic Genetic Testing
- 6.5.1 Overview
- 6.5.2 Diagnostic Genetic Testing: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7. South and Central America Genetic Testing Services Market Analysis – by Disease
- 7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.2 Cardiovascular Diseases
- 7.2.1 Overview
- 7.2.2 Cardiovascular Diseases: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.3 Metabolic Diseases
- 7.3.1 Overview
- 7.3.2 Metabolic Diseases: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 7.4 Other Diseases
- 7.4.1 Overview
- 7.4.2 Other Diseases: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8. South and Central America Genetic Testing Services Market Analysis – by Service Providers
- 8.1 Hospital-Based Laboratories
- 8.1.1 Overview
- 8.1.2 Hospital-Based Laboratories: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.2 Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Diagnostic Laboratories: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 8.3 Other Service Providers
- 8.3.1 Overview
- 8.3.2 Other Service Providers: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9. South and Central America Genetic Testing Services Market – Country Analysis
- 9.1 South and Central America
- 9.1.1 South and Central America Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
- 9.1.1.1 South and Central America Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
- 9.1.1.2 Brazil: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.1.1.2.1 Brazil: South and Central America Genetic Testing Services Market Share – by Service Type
- 9.1.1.2.2 Brazil: South and Central America Genetic Testing Services Market Share – by Disease
- 9.1.1.2.3 Brazil: South and Central America Genetic Testing Services Market Share – by Cancer Disease
- 9.1.1.2.4 Brazil: South and Central America Genetic Testing Services Market Share – by Service Providers
- 9.1.1.3 Argentina: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.1.1.3.1 Argentina: South and Central America Genetic Testing Services Market Share – by Service Type
- 9.1.1.3.2 Argentina: South and Central America Genetic Testing Services Market Share – by Disease
- 9.1.1.3.3 Argentina: South and Central America Genetic Testing Services Market Share – by Cancer Disease
- 9.1.1.3.4 Argentina: South and Central America Genetic Testing Services Market Share – by Service Providers
- 9.1.1.4 Colombia: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.1.1.4.1 Colombia: South and Central America Genetic Testing Services Market Share – by Service Type
- 9.1.1.4.2 Colombia: South and Central America Genetic Testing Services Market Share – by Disease
- 9.1.1.4.3 Colombia: South and Central America Genetic Testing Services Market Share – by Cancer Disease
- 9.1.1.4.4 Colombia: South and Central America Genetic Testing Services Market Share – by Service Providers
- 9.1.1.5 Chile: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.1.1.5.1 Chile: South and Central America Genetic Testing Services Market Share – by Service Type
- 9.1.1.5.2 Chile: South and Central America Genetic Testing Services Market Share – by Disease
- 9.1.1.5.3 Chile: South and Central America Genetic Testing Services Market Share – by Cancer Disease
- 9.1.1.5.4 Chile: South and Central America Genetic Testing Services Market Share – by Service Providers
- 9.1.1.6 Rest of South and Central America: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- 9.1.1.6.1 Rest of South and Central America: South and Central America Genetic Testing Services Market Share – by Service Type
- 9.1.1.6.2 Rest of South and Central America: South and Central America Genetic Testing Services Market Share – by Disease
- 9.1.1.6.3 Rest of South and Central America: South and Central America Genetic Testing Services Market Share – by Cancer Disease
- 9.1.1.6.4 Rest of South and Central America: South and Central America Genetic Testing Services Market Share – by Service Providers
- 10. Genetic Testing Services Market – Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies in Genetic Testing Services Market
- 10.3 Organic Growth Strategies
- 10.3.1 Overview
- 10.4 Inorganic Growth Strategies
- 10.4.1 Overview
- 11. Company Profiles
- 11.1 Eurofins Scientific SE
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Exact Sciences Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Laboratory Corp of America Holdings
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4andMe Holding Co
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Ambry Genetics Corp
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Quest Diagnostics Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Illumina Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 F. Hoffmann-La Roche Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 NeoGenomics Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Centogene NV
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
- 11.11 Ancestry Genomics Inc
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
- 11.12 Gene By Gene Ltd
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
- 11.13 SIVOTEC BioInformatics LLC
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
- 11.14 Progenesis
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
- 11.15 Fulgent Genetics, Inc
- 11.15.1 Key Facts
- 11.15.2 Business Description
- 11.15.3 Products and Services
- 11.15.4 Financial Overview
- 11.15.5 SWOT Analysis
- 11.15.6 Key Developments
- 11.16 VERITAS INTERCONTINENTAL
- 11.16.1 Business Description
- 11.16.2 Products and Services
- 11.16.3 Financial Overview
- 11.16.4 SWOT Analysis
- 11.16.5 Key Developments
- 11.17 GeneDx, LLC
- 11.17.1 Key Facts
- 11.17.2 Business Description
- 11.17.3 Products and Services
- 11.17.4 Financial Overview
- 11.17.5 SWOT Analysis
- 11.17.6 Key Developments
- 12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
- LIST OF TABLES
- Table 1. South and Central America Genetic Testing Services Market Segmentation
- Table 2. South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
- Table 3. South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Type
- Table 4. South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease
- Table 5. South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Providers
- Table 6. South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
- Table 7. Brazil: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
- Table 8. Brazil: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
- Table 9. Brazil: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
- Table 10. Brazil: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
- Table 11. Argentina: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
- Table 12. Argentina: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
- Table 13. Argentina: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
- Table 14. Argentina: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
- Table 15. Colombia: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
- Table 16. Colombia: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
- Table 17. Colombia: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
- Table 18. Colombia: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
- Table 19. Chile: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
- Table 20. Chile: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
- Table 21. Chile: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
- Table 22. Chile: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
- Table 23. Rest of South and Central America: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
- Table 24. Rest of South and Central America: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
- Table 25. Rest of South and Central America: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
- Table 26. Rest of South and Central America: South and Central America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers
- Table 27. Recent Organic Growth Strategies in Genetic Testing Services Market
- Table 28. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
- Table 29. Glossary of Terms, Genetic Testing Services Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.